Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Optimind Pharma Corp C.OMND

Healthcare Psychedelics
Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for... see more

Recent & Breaking News (CSE:OMND)

    CSE Bulletin: Halted for Fundamental Change - Optimind Pharma Corp. (OMND)

    Newsfile September 11, 2025

    Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk

    Newsfile September 8, 2025

    Canadian Investment Regulatory Organization Trading Halt - OMND

    Canada NewsWire September 8, 2025

    Optimind Pharma Announces Termination of Letter of Intent

    Newsfile September 4, 2025

    Canadian Investment Regulatory Organization Trade Resumption - OMND

    Canada NewsWire March 25, 2025

    Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business

    Newsfile March 24, 2025

    Canadian Investment Regulatory Organization Trading Halt - OMND

    Canada NewsWire March 21, 2025

    Optimind Pharma Closes Second Tranche of Private Placement

    Newsfile July 29, 2024

    Optimind Pharma Closes First Tranche of Private Placement

    Newsfile July 8, 2024

    Optimind Pharma - Private Placement

    Newsfile July 3, 2024

    Optimind Pharma Provides Corporate Update

    ACCESS Newswire December 19, 2023

    Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions

    GlobeNewswire October 12, 2023

    Optimind Pharma Corp. Announces Grant of Options

    Newsfile March 10, 2023

    Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy

    Newsfile September 20, 2022

    Canadian Securities Exchange Reports August 2022 Performance Figures

    Newsfile September 13, 2022

    Optimind (CSE:OMND) provides update on Health Canada's Dealer License under joint-venture with Manitari Pharma

    Brieanna McCutcheon  August 10, 2022

    Optimind Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma

    Newsfile August 10, 2022

    Optimind Pharma (CSE:OMND) commences trading on the CSE

    John Ballem  August 4, 2022

    Optimind Pharma Commences Trading on The CSE Under Ticker Symbol OMND

    Newsfile August 4, 2022